Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis
- 1 June 1996
- journal article
- Published by Springer Nature in Rheumatology International
- Vol. 16 (2), 45-48
- https://doi.org/10.1007/bf01816434
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction.1993
- Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.1992
- The role of interleukin 1, erythropoietin and red cell bound immunoglobulins in the anaemia of rheumatoid arthritis.1991
- Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritisThe American Journal of Medicine, 1990
- Iron chelation in rheumatoid arthritis: clinical and laboratory evaluation.Annals Of The Rheumatic Diseases, 1990
- The pathogenesis of anemia in rheumatoid arthritis: A clinical and laboratory analysisSeminars in Arthritis and Rheumatism, 1990
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Blunted erythropoietin response to anaemia in rheumatoid arthritisBritish Journal of Haematology, 1987
- Treatment of rheumatoid arthritis with desferrioxamine: relation between stores of iron before treatment and side effects.BMJ, 1985
- Reassessment of the Use of Desferrioxamine B in Iron OverloadNew England Journal of Medicine, 1976